Key Takeaway
What Doctor to See for Weight Loss Medication. Evidence-based answers from FormBlends, a physician-supervised telehealth weight loss clinic.
Here is what the current medical evidence says about what doctor to see for weight loss medication. At FormBlends, our physicians stay on top of the latest research to give patients clear, actionable information. Below we break down what you need to know, based on clinical data and our clinical experience.
What Does the Research Say About What Doctor to See for Weight Loss Medication?
The medical literature on what doctor to see for weight loss medication provides several key findings:
- GLP-1 receptor agonists work by mimicking natural gut hormones that regulate appetite and blood sugar
- Clinical trials have shown consistent weight loss results across diverse patient populations
- Side effects are primarily gastrointestinal and tend to improve during the first weeks of treatment
- Physician supervision is important for monitoring progress and adjusting dosing
How Does This Apply to Your Treatment?
Knowing what doctor to see for weight loss medication matters because it directly affects treatment decisions. At FormBlends, our physicians consider this information when building your personalized protocol. Every patient is different, and what works for one person may need adjustment for another.
View data table
| Category | Search Volume Share (%) | Detail |
|---|---|---|
| Side Effects | 35 | Nausea, GI issues |
| Cost/Insurance | 28 | Pricing questions |
| Effectiveness | 22 | How much weight loss |
| Eligibility | 15 | BMI requirements |
We recommend discussing what doctor to see for weight loss medication with your FormBlends physician during your consultation. They can explain how it applies to your specific health history and weight loss goals.
Clinical Evidence for GLP-1 Weight Loss Medications
The STEP trials for semaglutide (Wegovy) demonstrated significant weight loss across multiple studies. In STEP 1[1], participants lost an average of 14.9% body weight[1] over 68 weeks compared to 2.4% with placebo. The SURMOUNT trials for tirzepatide showed even greater results, with patients losing up to 22.5% body weight[2] at the highest dose (15mg) over 72 weeks. These medications work by activating GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →Liraglutide (Saxenda), approved in 2014, showed more modest results with 8% average weight loss[3] in the SCALE trials. Dosing typically starts at 0.25mg weekly for semaglutide, escalating to 2.4mg maintenance dose over 16-20 weeks. Tirzepatide begins at 2.5mg weekly, increasing to 5-15mg based on tolerance and efficacy. Common side effects include nausea (44% of patients), diarrhea (30%), and vomiting (24%), which typically resolve within 4-8 weeks of treatment initiation.
Clinical Evidence
The STEP-1 trial showed 86.4% of patients achieved at least 5% weight loss on semaglutide versus 31.5% on placebo. SURMOUNT-1[2] demonstrated that 91% of tirzepatide patients achieved 5%[1] weight loss, with 57% reaching 20% weight loss at the highest dose.
What Should You Do Next?
If you have questions about what doctor to see for weight loss medication, FormBlends can help. Our licensed physicians provide personalized guidance based on your medical history and goals. Start with a free online evaluation to connect with a provider who can answer your specific questions.
- Semaglutide for weight loss
- Tirzepatide for weight loss
- Compounded GLP-1 medications
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]
Get Personalized Answers
General information is a starting point, but your treatment should be tailored to you. FormBlends connects you with licensed physicians who can evaluate your situation and provide specific recommendations. Complete your free evaluation today.